Alm. Brand A/S – Weekly report on share buybacks 11

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
21
Alm. Brand A/S – Weekly report on share buybacks

11 February 2019 Announcement no. 8/2019

Alm. Brand A/S – Weekly report on share buybacks

In the period 4 February 2019 to 8 February 2019, Alm. Brand A/S bought own shares for a total amount of DKK 3.0 million as part of the share buyback programme of up to DKK 200 million announced on 28 February 2018. The share buy-back programme is expected to run until the end of March 2019. In aggregate, shares of DKK 189.7 million were bought back, equivalent to 94.9% of the overall programme.

Under the share buyback programme, the following transactions were made during week 6:

Date No. of shares Average purchase price (DKK) Transaction value  (DKK)
4 February 2019 12,195 55.92 681,944
5 February 2019 9,756 55.73 543,702
6 February 2019 12,195 56.36 687,310
7 February 2019 9,756 56.24 548,677
8 February 2019 9,756 55.46 541,068
Accumulated during the period 53,658 55.96 3,002,702
Accumulated under the share buyback programme 3,168,248 59.88 189,711,760

Danske Bank manages the share buyback programme, which is completed in accordance with Commission Regulation (EC) No. 596/2014 of 16 April 2014 (the “Market Abuse Regulation”).

Following the above transactions, Alm. Brand holds 4,639,059 own shares, equivalent to 2.9% of the share capital.

Transactional data relating to share buy-backs is provided on the following pages in detailed form and in aggregated form, in accordance with Commission’s Delegated Regulation (EU) 2016/1052 of 8 March 2016.

Contact Please direct any questions regarding this announcement to: Cristina Rønde Hefting, Investor Relations Manager, on tel. +45 35 47 79 22.

Detailed transaction data

  04 February 2019   05 February 2019   06 February 2019   07 February 2019   08 February 2019
  Number of shares VWAP DKK   Number of shares VWAP DKK   Number of shares VWAP DKK   Number of shares VWAP DKK   Number of shares VWAP DKK
XCSE 12.195 55,92   9.756 55,73   12.195 56,36   9.756 56,24   9.756 55,46
TRQX 0     0     0     0     0  
TRQM 0     0     0     0     0  
BATE 0     0     0     0     0  
BATD 0     0     0     0     0  
CHIX 0     0     0     0     0  
CHID 0     0     0     0     0  
Total 12.195 55,92   9.756 55,73   12.195 56,36   9.756 56,24   9.756 55,46
04 February 2019
Volume Price Venue Time CET
12.195 55,92    
29 56,10 XCSE 20190204 9:06:24.164000
227 56,00 XCSE 20190204 9:43:27.866000
327 56,00 XCSE 20190204 9:43:27.866000
375 56,00 XCSE 20190204 11:36:28.746000
236 56,00 XCSE 20190204 11:36:28.746000
134 55,90 XCSE 20190204 12:11:07.753000
804 55,90 XCSE 20190204 12:11:07.753000
100 55,90 XCSE 20190204 13:19:22.872000
330 55,90 XCSE 20190204 13:37:26.540000
304 55,90 XCSE 20190204 14:12:30.430000
447 55,90 XCSE 20190204 15:08:09.013000
374 55,90 XCSE 20190204 15:33:27.566000
214 55,80 XCSE 20190204 15:46:24.888000
144 55,80 XCSE 20190204 15:46:24.888000
128 55,90 XCSE 20190204 16:27:37.807178
13 55,90 XCSE 20190204 16:27:37.807178
13 55,90 XCSE 20190204 16:27:37.807178
280 55,90 XCSE 20190204 16:27:37.807178
521 55,90 XCSE 20190204 16:27:44.555974
7.195 55,92 XCSE 20190204 16:36:43.393952
05 February 2019
Volume Price Venue Time CET
9.756 55,73    
29 56,00 XCSE 20190205 9:01:24.232000
330 55,20 XCSE 20190205 9:25:15.673000
333 55,50 XCSE 20190205 10:03:49.976000
307 55,60 XCSE 20190205 10:27:53.385000
462 55,70 XCSE 20190205 11:45:14.279000
54 55,70 XCSE 20190205 11:45:14.279000
296 55,70 XCSE 20190205 12:42:08.586000
454 56,10 XCSE 20190205 14:26:12.860000
246 56,10 XCSE 20190205 14:26:12.860000
295 55,80 XCSE 20190205 15:01:51.856000
294 55,70 XCSE 20190205 15:51:46.677000
304 55,70 XCSE 20190205 16:03:47.592000
313 55,80 XCSE 20190205 16:19:28.268000
283 55,80 XCSE 20190205 16:27:06.908600
5.756 55,73 XCSE 20190205 16:29:07.674034
06 February 2019
Volume Price Venue Time CET
12.195 56,36    
29 56,10 XCSE 20190206 9:12:25.476000
100 56,10 XCSE 20190206 9:20:00.054000
324 56,70 XCSE 20190206 9:27:33.702000
614 56,40 XCSE 20190206 10:14:12.203000
298 56,40 XCSE 20190206 11:26:48.909000
544 56,30 XCSE 20190206 11:47:55.900000
300 56,10 XCSE 20190206 12:31:52.072000
440 56,30 XCSE 20190206 13:37:27.553000
153 56,30 XCSE 20190206 14:29:29.555000
180 56,30 XCSE 20190206 14:29:29.555000
309 56,20 XCSE 20190206 15:04:22.114000
1.709 56,40 XCSE 20190206 16:25:10.263537
7.195 56,36 XCSE 20190206 16:38:56.677175
07 February 2019
Volume Price Venue Time CET
9.756 56,24    
30 56,30 XCSE 20190207 9:02:06.069000
290 56,30 XCSE 20190207 9:27:30.019000
109 56,20 XCSE 20190207 9:58:56.628000
540 56,80 XCSE 20190207 10:15:59.644000
310 56,40 XCSE 20190207 11:15:10.907000
120 56,30 XCSE 20190207 12:17:48.607000
208 56,30 XCSE 20190207 12:17:48.607000
137 56,20 XCSE 20190207 12:42:31.636000
197 56,20 XCSE 20190207 13:09:02.757000
263 56,20 XCSE 20190207 13:42:41.860000
59 56,20 XCSE 20190207 13:42:41.860000
283 56,10 XCSE 20190207 14:25:00.229000
29 56,10 XCSE 20190207 14:25:00.229000
312 56,10 XCSE 20190207 15:07:34.414000
102 56,10 XCSE 20190207 15:34:26.100000
211 56,10 XCSE 20190207 15:34:26.100000
378 55,90 XCSE 20190207 16:25:58.186822
422 56,00 XCSE 20190207 16:29:26.310992
5.756 56,24 XCSE 20190207 16:36:32.766034
08 February 2019
Volume Price Venue Time CET
9.756 55,46    
30 56,10 XCSE 20190208 9:05:18.966000
880 55,80 XCSE 20190208 10:27:36.673000
338 55,90 XCSE 20190208 11:42:25.032000
347 55,90 XCSE 20190208 12:44:15.696000
148 55,90 XCSE 20190208 12:44:15.696000
311 55,80 XCSE 20190208 13:04:23.377000
117 55,40 XCSE 20190208 14:02:38.181000
191 55,40 XCSE 20190208 14:02:49.781000
317 55,10 XCSE 20190208 15:43:39.648000
654 55,00 XCSE 20190208 15:56:15.399000
316 54,90 XCSE 20190208 16:15:51.862000
351 54,90 XCSE 20190208 16:18:20.225686
5.756 55,46 XCSE 20190208 16:19:30.929750

 

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 3

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 28

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 5

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 169

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
Al Hurra Cuts Jobs and Merges Iraq Channel Amid Budget Cuts

Updated Category News Views 136

Al Hurra Faces Major Workforce Reductions The parent organization of the Arabic language broadcaster Al Hurra has announced significant layoffs, resulting in the elimination of 160 positions. This decision comes in the wake of a 20% budget cut mandated by the U.S. Congress, as revealed by the company’s CEO in a message to staff. Understanding the Budget Cuts Dr. Jeffrey...

Continue Reading
Strategies for Success in Hinge Research Institute's 2025 Study

Updated Category News Views 627

Innovative Strategies Highlighted in Hinge Research's 2025 Study Hinge Research Institute stands at the forefront of research on professional services growth. With its recent 10th Annual High Growth Study, the institute has delivered crucial insights into how successful firms thrive in today’s rapidly evolving market. The study not only illustrates the growth potential...

Continue Reading
Psyence Biomed Celebrates Milestones in Psilocybin Development

Updated Category News Views 125

Recent Developments in Psyence Biomed's Journey In a significant update shared by Psyence Biomedical Ltd. (Nasdaq: PBM), the company has showcased its achievements, reflecting a positive trajectory in the realm of psychedelic-based therapeutics. Highlights from the update included the impressive valuation of their stake in PsyLabs, strong clinical trial progress, and a...

Continue Reading
Rugby Resources Limited Expands Private Placement Offerings

Updated Category News Views 146

Rugby Resources Limited Expands Private Placement Opportunities Rugby Resources Ltd. (TSX-V: RUG) has announced an important development regarding its private placement offering. Responding to high subscriber demand, the company's board has authorized an increase in the number of available units, raising the offering from 60 million units to an impressive 81.84 million...

Continue Reading